Article
Structure of engineered hepatitis C virus E1E2 ectodomain in complex with neutralizing antibodies
5 Jul 2023
Abstract excerpt
Hepatitis C virus (HCV) is a major global health burden as the leading causative agent of chronic liver disease and hepatocellular carcinoma. While the main antigenic target for HCV-neutralizing antibodies is the membrane-associated E1E2 surface glycoprotein, the development of effective vaccines has been hindered by complications in the biochemical preparation of soluble E1E2 ectodomains. Here, we present a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
